Growth Hormone 1 | Ligand Page

gtopdb_logo_and_banner_image
  • Home
  • About
    • About The Guide to PHARMACOLOGY
    • About NC-IUPHAR
    • Database Content
    • Contributors
    • Sponsors
    • Citing
    • Linking to us
    • Disclaimer
    • Privacy and Cookie Policy
  • Targets
    • GPCRs
    • Ion channels
      • LGICs
      • VGICs
      • Other channels
    • Nuclear receptors
    • Kinases
    • Catalytic receptors
    • Transporters
    • Enzymes
    • Other protein targets
    • Target search
      • Target search tools
      • BLAST
  • Ligands
    • Ligand list
    • Ligand families
    • Ligand search
  • Diseases
  • Resources
    • Help
    • Tutorial
    • FAQ
    • Terms and symbols
    • Nomenclature guidelines
    • Publications
    • Downloads
      • Download data and reports
      • Web services
      • Slides and posters
    • News
      • Immunopharmacology Meeting 2018
      • Latest news
      • Hot topics
      • Latest pairings
    • Concise Guide to PHARMACOLOGY
    • Useful links
  • Advanced search
    • Target search
      • Target search tools
      • BLAST
    • Ligand search
    • Pharmacology search
  • Immuno Portal
  • Malaria Portal
Home About Help
  • Home
  • Ligands
  • growth hormone 1 (Human)

growth hormone 1 Click here for help

GtoPdb Ligand ID: 4943

Synonyms: NutropinAq® | Omnitrope® | Saizen® | somatotropin Approved drug growth hormone 1 is an approved drug (FDA (1976), EMA (2001)) Compound class: Endogenous peptide in human, mouse or rat Comment: Human growth hormone 1 (somatropin) produced by recombinant technology is an approved drug with the INN somatropin. This has identical 191-amino acid sequence to the endogenous hormone.Biosimilar drug: The EMA approved the biosimilar named Omnitrope (Sandoz GmbH) in 2006. Species: Human